FindTrial
Sign In

Association between LogeCHR and 28-day Mortality in ICU Patients with Sepsis: A Retrospective Cohort Study

Association between LogeCHR and 28-day Mortality in ICU Patients with Sepsis: A Retrospective Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600128565
Enrollment
Unknown
Registered
2026-07-22
Start date
2026-07-23
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spesis

Interventions

High LogeCHR group (Upper tertile):None
Intermediate LogeCHR group (Middle tertile):None
Low LogeCHR group (Lower tertile):None

Sponsors

Fuqing City Hospital of Fujian Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >= 18 years; 2.Diagnosis of sepsis according to the Sepsis-3.0? criteria; 3.Length of ICU stay >= 24 hours.

Exclusion criteria

Exclusion criteria: 1.History of end-stage renal disease (ESRD); 2.Known advanced-stage malignancy or terminally ill cancer prior to admission; 3.Severely incomplete clinical data.

Design outcomes

Primary

MeasureTime frame
28-day all-cause mortality;—

Secondary

MeasureTime frame
90-day all-cause mortality;—

Countries

China

Contacts

Public ContactXue Yan

Fuqing City Hospital of Fujian Province

70335954@qq.com+86 591 1234567

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026